28241068|t|Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
28241068|a|ATP-binding cassette transporter A1 (ABCA1) controls cholesterol and phospholipid efflux to lipid-poor apolipoprotein E (APOE) and is transcriptionally controlled by Liver X receptors (LXRs) and Retinoic X Receptors (RXRs). In APP transgenic mice, lack of Abca1 increased Abeta deposition and cognitive deficits. Abca1 haplo-deficiency in mice expressing human APOE isoforms, increased level of Abeta oligomers and worsened memory deficits, preferentially in APOE4 mice. In contrast upregulation of Abca1 by LXR/RXR agonists significantly ameliorated pathological phenotype of those mice. The goal of this study was to examine the effect of LXR agonist T0901317 (T0) on the phenotype and brain transcriptome of APP/E3 and APP/E4 Abca1 haplo-deficient (APP/E3/Abca1+/- and APP/E4/Abca1+/-) mice. Our data demonstrate that activated LXRs/RXR ameliorated APOE4-driven pathological phenotype and significantly affected brain transcriptome. We show that in mice expressing either APOE isoform, T0 treatment increased mRNA level of genes known to affect brain APOE lipidation such as Abca1 and Abcg1. In both APP/E3/Abca1+/- and APP/E4/Abca1+/- mice, the application of LXR agonist significantly increased ABCA1 protein level accompanied by an increased APOE lipidation, and was associated with restoration of APOE4 cognitive deficits, reduced levels of Abeta oligomers, but unchanged amyloid load. Finally, using Gene set enrichment analysis we show a significant APOE isoform specific response to LXR agonist treatment: Gene Ontology categories "Microtubule Based Process" and "Synapse Organization" were differentially affected in T0-treated APP/E4/Abca1+/- mice. Altogether, the results are suggesting that treatment of APP/E4/Abca1+/- mice with LXR agonist T0 ameliorates APOE4-induced AD-like pathology and therefore targeting the LXR-ABCA1-APOE regulatory axis could be effective as a potential therapeutic approach in AD patients, carriers of APOEepsilon4.
28241068	104	109	Abca1	Gene	11303
28241068	126	130	mice	Species	10090
28241068	169	174	ABCA1	Gene	11303
28241068	185	196	cholesterol	Chemical	MESH:D002784
28241068	201	213	phospholipid	Chemical	MESH:D010743
28241068	224	229	lipid	Chemical	MESH:D008055
28241068	235	251	apolipoprotein E	Gene	11816
28241068	253	257	APOE	Gene	11816
28241068	374	378	mice	Species	10090
28241068	388	393	Abca1	Gene	11303
28241068	404	409	Abeta	Gene	11820
28241068	425	443	cognitive deficits	Disease	MESH:D003072
28241068	445	450	Abca1	Gene	11303
28241068	471	475	mice	Species	10090
28241068	487	492	human	Species	9606
28241068	493	497	APOE	Gene	348
28241068	527	532	Abeta	Gene	11820
28241068	556	571	memory deficits	Disease	MESH:D008569
28241068	597	601	mice	Species	10090
28241068	631	636	Abca1	Gene	11303
28241068	640	643	LXR	Gene	22259
28241068	715	719	mice	Species	10090
28241068	785	793	T0901317	Chemical	MESH:C423915
28241068	795	797	T0	Chemical	MESH:C423915
28241068	861	866	Abca1	Gene	11303
28241068	891	896	Abca1	Gene	11303
28241068	911	916	Abca1	Gene	11303
28241068	921	925	mice	Species	10090
28241068	1084	1088	mice	Species	10090
28241068	1107	1111	APOE	Gene	11816
28241068	1121	1123	T0	Chemical	MESH:C423915
28241068	1186	1190	APOE	Gene	11816
28241068	1210	1215	Abca1	Gene	11303
28241068	1220	1225	Abcg1	Gene	11307
28241068	1242	1247	Abca1	Gene	11303
28241068	1262	1267	Abca1	Gene	11303
28241068	1271	1275	mice	Species	10090
28241068	1332	1337	ABCA1	Gene	11303
28241068	1380	1384	APOE	Gene	11816
28241068	1442	1460	cognitive deficits	Disease	MESH:D003072
28241068	1480	1485	Abeta	Gene	11820
28241068	1511	1518	amyloid	Disease	MESH:C000718787
28241068	1591	1595	APOE	Gene	11816
28241068	1760	1762	T0	Chemical	MESH:C423915
28241068	1778	1783	Abca1	Gene	11303
28241068	1787	1791	mice	Species	10090
28241068	1857	1862	Abca1	Gene	11303
28241068	1866	1870	mice	Species	10090
28241068	1888	1890	T0	Chemical	MESH:C423915
28241068	1917	1919	AD	Disease	MESH:D000544
28241068	1963	1966	LXR	Gene	22259
28241068	1967	1972	ABCA1	Gene	11303
28241068	1973	1977	APOE	Gene	11816
28241068	2052	2054	AD	Disease	MESH:D000544
28241068	2055	2063	patients	Species	9606
28241068	Association	11303	11816
28241068	Positive_Correlation	MESH:C423915	11307
28241068	Association	MESH:D000544	11816
28241068	Association	11307	11816
28241068	Association	MESH:D010743	11816
28241068	Association	MESH:D003072	11816
28241068	Negative_Correlation	MESH:C423915	MESH:D000544
28241068	Positive_Correlation	MESH:C423915	11816
28241068	Positive_Correlation	11303	22259
28241068	Association	MESH:D008569	11303
28241068	Association	MESH:D003072	11303
28241068	Negative_Correlation	11303	11820
28241068	Association	11303	348
28241068	Positive_Correlation	MESH:C423915	11303
28241068	Association	MESH:D000544	22259

